Enhancing the Usability of Drug Materials by Electrostatic Atomisation by Nyström, Maija
Maija Nyström
TURUN YLIOPISTON JULKAISUJA –  ANNALES UNIVERSITATIS TURKUENSIS
Sarja - ser. AI osa  - tom. 501 | Astronomica - Chemica - Physica - Mathematica | Turku 2014
ENHANCING THE USABILITY 










Department of Physics and Astronomy
University of Turku
Turku, Finland
University of Turku 
Faculty of Mathematics and Natural Sciences





Institute of Fluid Flow Machinery











Department of Chemical and Biomolecular 
Engineering
Case Western Reserve University
USA
The originality of this thesis has been checked in accordance with the University of Turku 








This work has been carried out in the Laboratory of Industrial Physics, at the 
University of Turku, during 2010 – 2014. I wish to thank the Academy of Fin-
land and Finnish Academy of Science and Letters for the financial support for 
this period.  
First of all,  I am deeply grateful to my supervisors, Drs. Matti Murtomaa 
and  Jarno  Salonen  for  constantly  being  ready  to  guide  and  share  their  
expertise. Being respectable scientists yourself you set the bar high, but I was 
never  alone  trying  to  cross  it.  When  I  first  started  at  the  Laboratory  of  
Industrial Physics as a summer trainee in 2006, I was supposed to become a 
schoolteacher. After that summer, being supervised and bossed around by 
Matti, I never left. I am grateful to Matti for his belief in me. Ever since I was 
a rookie you would encourage me to put my ideas, which were quite crude 
sometimes, into practise. You supervised my bachelor’s,  master’s and finally 
doctoral thesis, and told me “you did well” when it was most needed.  
I also want to thank all the past and present members of the Laboratory of 
Industrial Physics for creating the casual and inspiring working atmosphere. 
Everybody has always been ready to use their time to help one another, which 
I  believe  is  exceptional.  With  my  long-time  fellow  students  Ermei  Mäkilä,  
Martti Kaasalainen, Tero Jalkanen, Jaani Tuura, Luke Jäppinen and Jorma 
Roine, we would share the moments of both joy and frustration that are such 
an integral  part  of  the  doctoral  studies.  I  will  never  forget  the  sense  of  soli-
darity, when I would work late in the quiet, dark university, take a break and 
notice  a  warm  beam  of  light  falling  on  the  corridor  from  someone  else’s  
office: “Oh, you are still here too!”.  
I express my gratitude to my opponent, Prof. Daniel Lacks. I am honored 
to  have you as  an opponent.  Prof.  Anatol  Jaworek and Prof.  Thomas Rades  
are  acknowledged  for  reviewing  this  thesis.  The  co-authors  MSc.  Jorma  
Roine, Prof. R. Mohan Sankaran and Dr. Hélder A. Santos are also gratefully 
acknowledged for lending their expertise.  
All  my  friends  deserve  a  big  thank  you.  My  dear  long-time  girlfriends  
Maria  and  Leeni  have  been  invaluable.  Let’s  continue  to  keep  our  nostrils  
above the water level. Ville, Joppe, Antti and Pexi, you rock my world! I have 
also been lucky enough to get a bunch of great in-laws. Thank you to you all. 
4 
 
I wish to thank my family starting with Mikko, my big brother. That is in-
deed what you have always been to me. You and Laura, and your three little 
bundles of joy, Fanny, Linnea and Lenni are so dear to me. Thank you to my 
parents,  Tuula  and  Sakari,  for  the  unending  support  and  love  that  you  give  
me.  I  would not  be  here  if  I  had not  inherited at  least  a  bit  of  my mother’s  
persistence and my father’s positiveness and curiosity.  
Finally,  I  want  to  thank  my  beloved  Jorma.  You  continue  to  amaze  me  
with the sharpness of your brain and warmth of your heart. Yhes myö 
taistellaan. 
 






Electrospraying or electrostatic atomisation is a process of liquid disruption 
by electrostatic forces. When liquid is brought into an electric field, charge is 
induced to its surface. Once the repulsive electrostatic force exceeds the liquid 
surface tension, the liquid disrupts into small highly charged droplets. The 
size of the electrosprayed droplets can range from hundreds of micrometers 
down to a few tens of nanometers.  
Electrospraying  can  be  used  not  only  to  produce  droplets,  but  also  solid  
particles. The research presented in this thesis concentrates on producing 
drug  particles  by  this  method.  In  the  experiments,  a  drug  powder  was  
dissolved in a convenient solvent and the solution was atomised. The solvent 
was then evaporated from the formed droplets in a drying medium and inside 
each droplet, a dense cluster of the dissolved drug remained. From the 
pharmaceutical point of view, the most important characteristics of the 
produced particles are size distribution, porosity, crystal form and degree of 
crystallinity. These properties affect the dissolution behaviour and ultimately 
the drug bioavailability in the body. The effects of electrostatic atomisation 
on the aforementioned characteristics are generally not well understood. The 
research focused on studying these particle properties and finding possible 
correlations with the spraying parameters. 
The produced droplets were dried either under atmospheric or reduced 
pressure, the latter in order to improve the drying process. Special emphasis 
was put on implementing the spraying under reduced pressure, and the 
effects of the drying pressure on particle properties. Based on the results, the 
possibilities to enhance the dissolution of poorly soluble drugs by this method 
were estimated. In the course of experiments, it was also discovered that 
electrospraying may have a profound effect on the polymorphic form of the 
produced drug particles. In the light of the obtained results, it was concluded 
that electrospraying may offer a valuable tool to overcome some of the 





Sähköstaattinen sumutus (sähköstaattinen atomisaatio) on menetelmä, jolla 
neste voidaan hajottaa pieniksi pisaroiksi. Kun neste altistetaan 
sähkökentälle, sen pintaan indusoituu varaus. Sähköisen hylkimisvoiman 
ylittäessä nesteen pintajännityksen hajoaa nestesuihku voimakkaasti 
varautuneiksi pisaroiksi. Sähköstaattisella atomisaatiolla tuotettujen 
pisaroiden koko voi vaihdella sadoista mikrometreistä muutamiin 
kymmeniin nanometreihin. 
Nestepisaroiden tuottamisen lisäksi sähköstaattista sumutusta voidaan 
käyttää kiinteiden partikkeleiden valmistukseen. Väitöskirjatutkimuksessa on 
keskitytty lääkepartikkeleiden tuottamiseen tällä menetelmällä. 
Tutkimuksissa lääkejauhe liuotettiin sopivaan liuottimeen ja liuos 
atomisoitiin. Tämän jälkeen liuotin poistettiin höyrystämällä, ja pisaroiden 
sisässä liuotetusta lääkeaineesta muodostui tiivis klusteri. Farmaseuttisessa 
mielessä valmistettujen partikkeleiden tärkeimpiä ominaisuuksia ovat 
kokojakauma, huokoisuus, kidemuoto ja kiteisyysaste. Nämä vaikuttavat 
materiaalin liukenemiseen, ja lopulta myös lääkkeen biologiseen 
hyötyosuuteen elimistössä. Sähköstaattisen atomisaation vaikutukset edellä 
mainittuihin ominaisuuksiin eivät ole yleisesti tunnettuja. Tutkimuksissa 
selvitettiin näitä partikkelien ominaisuuksia sekä mahdollista korrelaatiota 
sumutusparametrien kanssa. 
Tuotetut pisarat kuivatettiin joko normaalissa ilmanpaineessa tai 
alennetussa paineessa. Jälkimmäisellä vaihtoehdolla kuivausta pyrittiin 
tehostamaan. Erityisesti alennetussa paineessa tapahtuvaa sumutusta sekä 
kuivauspaineen vaikutusta partikkelien ominaisuuksiin tutkittiin. Tulosten 
perusteella arvioitiin mahdollisuuksia hyödyntää kuvattua menetelmää 
niukkaliukoisten lääkeaineiden liukoisuuden parantamisessa. Tutkimuksissa 
havaittiin myös, että sähköstaattinen sumutus saattaa oleellisesti vaikuttaa 
tuotettujen partikkeleiden polymorfiseen muotoon. Tulosten perusteella 
pääteltiin, että sähköstaattinen atomisaatio voi tarjota varteenotettavan 
keinon ratkaista joitakin moderniin lääkekehitykseen ja formulointiin 
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Regardless of the somewhat misleading designation, atomisation is generally 
not related to materials in the atomic scale. Atomisation in the scope of this 
thesis  refers  to  modifying a  bulk  of  liquid into a  fine  spray.  A spray in  turn 
stands  for  essentially  the  same  as  in  the  colloquial  language:  a  two-phase  
system of droplets flowing within a gas [1].  
Transforming a  liquid bulk  into a  spray requires  energy.  It  is  needed  to  
overcome  the  viscous  forces  of  the  liquid  and  formation  of  the  new  surface  
[2].  In  pneumatic  and rotary  atomisers  this  energy is  mechanical,  but  it  can 
also be originated from an electric field.  The process of liquid disruption by 
electrostatic forces is known as electrostatic atomisation. In this thesis, 
utilising this phenomenon to produce droplets with a continuous liquid flow 
is referred to as electrospraying. The presented research concentrates on 
fabricating solid drug particles by this method.  
In  the  pharmaceutical  industry,  the  proportion  of  drug  candidates  with  
relatively poor biopharmaceutical properties is vast. Dissolution is a major 
problem for drugs with poor aqueous solubility. While there are several 
approaches  available  to  improve  the  dissolution  of  such  materials,  each  
process  has  its  limitations  and may not  be  suitable  for  a  certain application.  
Therefore various approaches to overcome the problem are required. The 
apparatus  generally  used  for  particle  production  by  electrospraying  exhibit  
low-volume throughput, and are adequate only for the laboratory scale. 
However, the production scale can be increased to meet the requirements of 





2.1 Electrostatic atomisation 
When a liquid is pumped through a capillary into an electric field, charge 
is  induced  to  its  surface.  The  charge  exerts  a  repulsive  force  on  the  
surface, which modifies the shape of the liquid meniscus. Once the 
electrostatic force exceeds the liquid surface tension, the surface becomes 
unstable  and  the  jet  disrupts  into  small  droplets.  In  a  convenient  
magnitude  of  the  electric  field,  the  meniscus  gets  a  conical  form  and  
small highly charged droplets eject from the cone tip [3]. This process is 
known as electrostatic atomisation. A typical setup for utilising the 
phenomenon is presented in Fig. 1. 
 
Fig.1. Schematic of the main components of electrostatic atomisation and elec-
trospraying. The liquid flows through a capillary, which is connected to a high 
voltage (HV) source. The plate electrode beneath is grounded. 
The high-intensity electric field necessary for the atomisation can be formed 
by concentrating the field to a small region, for example to a capillary tip. The 
most common electrode configuration is the capillary – plate or capillary – 
ring  pair  [4–6].  Usually  the  capillary  is  connected  to  a  high  voltage  (HV)  
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supply and the counter electrode is grounded, but also the inverse connection 
(with the HV on the counter electrode and ground on the capillary) is 
possible [1,4]. The electrode configuration can also be modified by other 
means depending on the  application,  for  example  by using a  grounded disc  
with  a  hole  in  the  centre  for  sampling  or  introducing  additional  electrodes  
[5,7–11]. 
2.1.1 Energy requirements 
Atomising  an  initial  volume  of  liquid  into  smaller  droplets  requires  energy.  
As reviewed by Cross (1987), energy is expended above all in three processes: 
formation of  a  new surface,  overcoming the  viscous  forces  of  the  liquid and 
energy dissipation [2]. The energy US required for the formation of the new 
surface  has  been estimated by Bailey  (1988)  [4].  If  an initial  spherical  liquid 
volume with radius R is atomised into n pieces  of  droplets  with  radius  r 









where  is the surface tension and  the density of the liquid.  
In the atomisation process, the liquid changes from a continuous bulk to a 
dispersed  state,  and  its  dimensions  change  significantly.  Monk  (1952)  ap-
proximated the energy UV required  for  the  shape  change  by  considering  a  
liquid flow through a conical body: in from the large end (input diameter d1) 
with a low velocity v1 and out of the narrow end (output diameter d2) with a 








where Q is  the  liquid volume flow rate  and L is  the  length of  the  cone [12].  
The energy required for the formation of the new surface is usually higher 
than the energy consumed due to the viscous effect [2].  
Energy  is  also  lost  in  the  form  of  Joule  heating  of  the  liquid  and  the  
possible  electrical  breakdown  processes  [2,4].  In  electrospraying,  the  jet  
deforms and disrupts mainly due to the electrostatic force, and no additional 
mechanical energy, for example in the form of forcing the liquid through a 
nozzle with pressure, is needed [13]. 
2.1.2 Liquid deformation 
In electrostatic atomisation, the electric field induces stress on the liquid 
surface. The total electrically induced force (Fe) consists of components 
normal (Fen) and tangential (Fet) to the surface. The relative magnitude of the 
components has been reported to depend on the liquid conductivity. On low 
conductivity organic solvents, the tangential component is dominant. For 
conductive  liquids,  metals  for  instance,  the  predominant  component  of  the  
electrostatic  force   is  normal  to  the  surface  [14].  This  is  due  to  the  distinct  
routes of charge convection in the materials: in a conductive liquid the charge 
can  be  transported  through  the  bulk,  but  in  a  low  conductivity  liquid  the  
charge is convected mainly on the surface [15].  
On top of the electrostatic and liquid surface tension forces 
(Fe and F ),  also  the  viscous  and  inertial  forces  (F  and Fi) which oppose 
the liquid movement, gravity (FG) and electrostatic repulsion between the 
formed  droplets  (Fq) act  on  the  liquid  cone  and  jet.  These  forces  are  
illustrated in Fig. 2. The lengths of the arrows in Fig. 2 do not refer to the 
force magnitudes, only their directions in the macroscopic view. 
2.1.3 Rayleigh limit 
In an electrically charged droplet, the limit at which the repulsive electrostatic 
force becomes larger than the attractive surface tension force, is known as the 
Rayleigh limit [16]. It sets an upper limit for the charge q that can be carried 




Fig. 2. Forces acting on the liquid cone in electrostatic atomisation: normal and 
tangential components of the electrically induced force (Fen  and Fet); surface 
tension (F ); viscous and inertial forces (F  and Fi); gravity (FG); and 
electrostatic repulsion between the formed droplets (Fq). 
 = 64 (3) 





where 0 is the permittivity of free space,  is the surface tension, r and m are 
the  droplet  radius  and  mass,  and   is  the  liquid  density.  In  electrospraying,  
the disruption takes place already at lower levels of charge, according to some 
estimates close to one-half of that predicted by the Rayleigh limit [13,17–20]. 
2.2 Functioning modes 
Electrostatic atomisation progresses through several visual and measurable 
changes, when the capillary voltage is increased and the liquid flow rate main-
tained constant. The different spraying regimes are called modes. In his pio-
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neering work on electrified liquids, this phenomenon was described and illus-
trated roughly a century ago by Zeleny (1916 and 1917) [21,22].  
Since the droplets formed in electrostatic atomisation are highly 
charged,  the  stability  and  functioning  mode  of  the  spray  can  be  
monitored by measuring the electric current (I) carried by the droplets 
[19,23,24].  When  the  voltage  at  the  capillary  tip  (U) is increased, the 
dripping frequency and I increase accordingly. The most important 
functioning modes and I as  a  function  of  U on  ethanol  are  presented  in  
Fig. 3. The measurement was done by first increasing the U up  to  the  
maximum value,  and then decreasing it  back to  the  starting value,  using 
voltage intervals of 0.1 kV and constant liquid flow rate. A more detailed 
description of the measurement is given in Paper I. 
 
Fig. 3. On the left, photographs of the different spraying modes on ethanol: 
a) dripping mode, b) pulsating mode, c) cone-jet mode and d) multi-jet mode 
[24]. On the right, the electric current I carried by ethanol droplets versus the 
applied voltage U. The letters a, b, c and d correspond to the different spraying 
modes [25].  
The dripping mode (Fig. 3a; U = 2.2  –  2.6  kV) is  generally  characterised by 
production  of  large  droplets  at  low  frequency  [6].  Therefore  also  I remains 
low.  This  mode  is  obtained  when  the  electric  field  is  absent,  and  with  low  
values of U.  Depending  on  the  liquid  properties,  wettability  of  the  capillary  
and liquid flow rate, the droplet diameter may be smaller or larger than that 
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of  the  capillary.  The  former  mode  is  referred  to  as  micro  dripping  [26,27].  
When U is increased, the dripping frequency increases, and the droplets 
become  smaller.  The  liquid  meniscus  alternates  between  a  round  and  a  
conical form, and an increase in I is  detected.  This  phase  is  called pulsating 
mode (Fig. 3b; U = 2.7  –  2.9  kV).  In  the  dripping and pulsating modes,  the  
main droplets may be accompanied with formation of smaller satellite 
droplets. 
When U is  increased  further  up  to  the  critical  value  of  3.0  kV,  I rises 
sharply and the liquid meniscus changes abruptly to a conical shape. This is 
the  usually  desired  cone-jet  mode  (Fig.  3c).  Taylor  (1964)  showed  that  a  
liquid surface  gets  a  conical  form in a  strong electric  field,  which is  stable  if  
the half-angle of the cone apex is equal to 49.3 ° [28]. Therefore, the liquid 
cone is  often referred to  as  Taylor  cone [29].  The cone-jet  domain with the  
current setup is between 3.0 and 4.0 kV. A hysteresis phenomenon is detected 
in the appearance of this mode when U is decreased. When U is further 
increased above 4.0 kV, the meniscus becomes unstable and multiple jets 
appear  on  the  cone.  The  number  of  the  emitting  jets  increases  with  the  
increasing U, and I rises sharply again [3]. This mode is called multi-jet mode 
(Fig. 3d).  
The droplet formation mechanism at the liquid meniscus can also be 
classified more broadly into just two categories: dripping (Fig. 3a and b) and 
jetting (Fig. 3c and d) [5,26]. Alternatively, a more detailed classification can 
be done by studying the intermediate forms of the modes, ramification of the 
jet and the detailed shape of the cone [8,19,26,27]. Moreover, not all of the 
above-mentioned modes appear on all liquids: for example the multi-jet 
mode is not detected on water. Although transitions between modes are not 
always  clearly  defined  and  overlap  regions  exist,  different  spraying  modes  
may lead to very different characteristics of the produced aerosols. Therefore 
distinguishing and controlling the regime at which the spray operates, is 
fundamental [3,5,27].    
2.3 Electrospray operation 
The size of the electrosprayed droplets can range from hundreds of 
micrometers  down to  a  few tens  of  nanometers,  and the  size  distribution is  
usually nearly monodisperse [6,19]. In addition to the electric field strength, 
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the droplet formation is affected by the solvent properties (internal 
conditions) and the geometry and operation of the electrospraying apparatus 
(external conditions).  
 2.3.1 Internal conditions 
Electrical  relaxation time of  a  liquid is  given by the  product  of  its  resistivity  
and absolute permittivity, and it determines the rate at which electric charge 
relaxes  from  the  liquid  bulk  to  its  surface.  Regarding  the  droplet  formation  
and electrospraying, this quantity is of primary importance [4]. While liquid 
resistivities may range over several orders of magnitudes, the permittivities 
range within a much narrower region. Therefore the resistivity has a more 
profound  effect  on  the  relaxation  time  [30].  When  the  conductivity  of  an  
electrospraying solvent increases (with the other solvent properties remaining 
constant),  the  amount  of  charge  on the  liquid surface  can grow higher,  and 
the obtained droplets become smaller [3,6,10,23,30]. The drawback of the 
increased charge density is that it causes irregular lateral motion inside the 
cone  and  wider  droplet  size  distribution  [3,30].  Liquids  with  very  low  
conductivity  cannot  be  atomised  using  electrostatic  forces:  estimates  of  this  
lower limit vary between 10-8 – 10-11 S/m [3,23,30,31].     
According to Eq. (1), the energy needed for the surface formation during 
atomisation is proportional to the surface tension of the liquid. Liquids with 
low surface tension can be atomised in a relatively weak electric field. Instead, 
liquids with high surface tension such as water, may require electric fields 
that are high enough to exceed the breakdown threshold of the surrounding 
gas (Chapter 2.3.2) [3,23,32]. The surface tension of an organic solvent can be 
reduced by adding surfactants, and the effect of surfactants on the droplet size 
in electrospraying has been reported to be marginal [10,23].  
According to Eq. (2), the energy required for the jet formation depends 
also on the liquid viscosity, which affects the jet breakup at the capillary tip. 
On a viscous solvent, the liquid filament forming at the cone apex is long and 
the disrupted droplets are large [23,30]. However, also contradictorily results 
have been reported on a setup utilising AC voltage excitation (Chapter 2.3.2): 
an increase in the viscosity caused a decrease in the jet diameter and droplet 
size  on water/glycol  mixtures  [33].  AC excited and direct  voltage  setups  are  
nevertheless quite different, and changing the liquid properties independently 
from each other may not be possible.  
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2.3.2 External conditions 
As mentioned previously, the droplet size and charging are strongly affected 
by the mode of spraying. Increasing the capillary voltage leads to formation of 
smaller droplets, but the electrical breakdown strength of the surrounding gas 
sets an upper-limit for the voltage. A discharge momentarily reduces the 
electric  field  strength,  and  results  in  fairly  broad  droplet  size  distributions  
[34].  This  problem  can  be  overcome  by  executing  the  electrospraying  in  an  
atmosphere with a higher electrical breakdown threshold than air, such as 
vacuum or sheath gas [5,19,21,24,34–39]. In addition to the applied voltage, 
the electric field strength is affected by the diameter of the capillary and the 
distance between the high voltage and grounded electrodes. In the cone-jet 
mode, the size of the capillary has been reported to affect the droplet size 
[4,6,18].  
Various models for the dependency between liquid flow rate and droplet 
size in the cone-jet mode have been presented. De la Mora and Loscertales 
(1994)  stated  that  the  droplet  size  is  proportional  to  the  cubic  root  of  the  
liquid flow rate,  while  Gañan-Calvo (1999)  calculated the  proportionality  to  
the square root of the flow rate [15,29]. Regardless of the lack of indisputable 
knowledge,  the  effect  of  liquid flow rate  on the  droplet  size  is  apparent:  the  
smaller  the  flow  rate,  the  smaller  the  droplet  size.  Depending  on  the  liquid  
properties,  there  is  a  minimum  flow  rate  at  which  electrospraying  can  be  
implemented in a steady state [40]. 
The  droplet  formation  can  also  be  regulated  by  harmonic  jet  excitation.  
The periodic oscillations at the liquid meniscus can be accomplished either by 
mechanical [41,42] or electrical methods [20,33,43–47]. The jet source can be 
vibrated mechanically for example by a piezo-electric transducer. With the 
latter method, a pulsed or AC voltage is superimposed on the DC voltage at 
the  capillary  tip,  and uniform droplets  can be  produced synchronously  with 
the voltage oscillations. 
2.4 Particle production 
The electrospraying process can be used not only to produce liquid droplets, 
but  also  solid  particles.  In  drug  particle  production,  the  drug  powder  is  
dissolved  in  a  convenient  solvent  and  the  solution  is  atomised  using  
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electrostatic forces. The jet disrupts into droplets which are highly charged 
and relatively uniform in size, and the charge of the same sign prevents the 
coalescence  of  the  droplets  [13].   The  solvent  is  then  evaporated  from  the  
formed  droplets  in  a  drying  medium,  and  a  dense  cluster  of  the  dissolved  
drug remains. The size of the produced particles can be controlled by varying 
the concentration of the dissolved material and the previously mentioned 
internal and external spraying conditions [6,30].  
2.4.1 Neutralisation 
The highly charged droplets produced by electrospraying repel each other 
and  drift  in  the  direction  governed  by  the  electric  field.  As  the  liquid  
evaporates, the droplets’ mass decreases and they may disrupt again at the 
Rayleigh  limit.  In  order  to  maintain  continuous  and  stable  droplet  
production, it is often favourable to remove the electric charge from the 
droplets by introducing a neutralisator to the system. The neutralised 
droplets can be directed to the collector for example by air flow or gravity. 
The functioning of the static charge neutralisators is based on ion produc-
tion. The ions increase the conductivity of the surrounding gas, which allows 
the neutralisation of the charged bodies. The ion production can be based for 
example  on  corona  discharge.  The  discharge  occurs  when  a  high  voltage  is  
applied between two electrodes, one of which is a sharp spike or a thin wire. 
The strong electric field near the sharp electrode causes a discharge in the 
surrounding gas resulting in an avalanche of electrons and formation of ions 
[2]. The corona neutralisator can be operated either with direct or alternating 
voltage. Other appropriate techniques to eliminate the droplets’ charge are 
radioactive neutralisators and electrospraying two liquids from adjacent 
capillaries with opposite polarities [19,24,48–50].  
2.4.2 Drying and collecting 
In order to acquire solid particles by electrospraying, the solvent and the dis-
solved  material  need  to  be  separated  by  vaporising  the  solvent.  The  drying  
phase in electrospraying is similar to the spray drying method, which is used 
in diverse industrial fields [51–53]. In the spray drying process, a solution or 
dispersion is atomised for example by rotary discs or pneumatic nozzles, after 
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which it is set in contact with a hot drying gas. Also in applications based on 
electrostatic atomisation, the drying can be done in an elevated temperature 
or reduced pressure to enhance the solvent vaporisation [13,54–56]. 
Naturally, also the distance between the capillary and the collecting interface 
affects the drying efficiency. The dried particles can be collected depending 
on the subsequent treatment on grounded surfaces, membrane filters, sample 
holders or in receiving liquids [10,39,56–60]. 
2.4.3 Upscaling 
A single capillary electrospraying system is mainly adequate for laboratory re-
search scale. Increasing the liquid flow rate or concentration of the dissolved 
material leads to larger droplet and particle sizes, which in turn would require 
compensating by increasing the electric field strength to form a stable cone or 
multi-jet  spraying  mode.  This  is  possible  only  up  until  the  electrical  
breakdown  threshold  of  the  surrounding  gas.  The  yield  of  the  process  can  
hence be improved only slightly by increasing the aforementioned 
parameters. Also, using small capillaries is essential.  
The  process  can  be  upscaled  to  a  higher  level  of  throughput  by  using  a  
linear  array  of  capillaries  [9,61–63].  Constant  liquid flow is  delivered to  the  
emitters, and each capillary works similarly to a basic, single nozzle unit. The 
capillaries  can  also  be  replaced  by  planar  array  of  holes  machined  on  a  
substrate [64–67]. In such systems, the proximity of the capillaries influences 
the electric field. In order to attain a product of uniform quality, irregularities 
in the liquid flow to each capillary and interaction of nozzles need to be taken 
into account. Also by carefully optimising the internal and external spraying 





3 Electrospraying of pharmaceutical materials 
The main objective of the research presented in this thesis was to study 
certain properties of the drug particles produced by electrospraying, and the 
possibilities to tailor these properties. In the pharmaceutical sense, the most 
important characteristics of the particles are size distribution, porosity, crystal 
form and degree of crystallinity. These affect the dissolution behaviour of the 
drug,  and  ultimately  the  bioavailability  in  the  body.   In  the  following,  the  
most  important  particle  properties  and  the  role  of  electrospraying  in  
determining them are discussed.   
3.1 Particle properties 
3.1.1 Dissolution 
The  proportion  of  drug  candidates  with  relatively  poor  biopharmaceutical  
properties, particularly in the form of low water solubility, has increased 
significantly over the past twenty years [69–76]. In drug discovery setting, the 
compounds found by high throughput screening tend to shift towards more 
lipophilic and higher molecular weight profile and therefore the new 
compounds are less soluble [71,77,78]. Dissolution is a major problem for 
orally administered drugs with poor aqueous solubility, which results in low 
bioavailability [79–83]. While there are several approaches available to 
improve the dissolution, such as salt formation, particle size reduction, 
prodrug formation and complexication,  each process  has  its  limitations  and 
may  not  be  suitable  for  a  certain  application.  Therefore  various  approaches  
are required.  
The dissolution of  a  drug from a  solid  dosage form involves  at  least  two 
consecutive  steps:  liberation  of  the  drug  from  the  solid  to  the  liquid  phase  
(disintegration) and migration of the drug molecules to the bulk of the 
solution (solubilisation). The overall dissolution rate depends on the slower 
one of these processes [84,85]. Dissolution test determines the cumulative 
amount  of  drug that  is  released into the  solution as  a  function of  time [85].  
The dissolution rate can be formulated by the well-known Noyes-Whitney 
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equation (1897), which was modified in the following form by Brunner 
(1904): 
 
= ( ) (5) 
where dC/dt is the dissolution rate, D is the diffusion coefficient of the drug 
in the solution, S is the interfacial surface area of the exposed solid drug, V is 
the volume of the solution, h is the thickness of the diffusion boundary layer, 
Cs is the concentration of a saturated solution of the drug at the surface of the 
solid, and Ct is  the  concentration  of  the  drug  in  the  bulk  medium  at  time  t 
[86]. Based on equation (5), the dissolution rate is proportional to the surface 
area of the dissolving particles. Hence it can be concluded that the dissolution 
can be enhanced for example by decreasing the particle size and increasing 
the porosity of the particles.  
3.1.2 Particle size 
By size reduction, the specific surface area of the drug particles can be 
increased.   Also  the  thickness  of  the  diffusion  boundary  layer  h is  small  on  
micronized and nanosized particles [87,88]. This results in a faster transport 
of  the  dissolved  material  from  the  solid  –  liquid  surface  to  the  bulk  of  the  
solution,  which  in  turn  enhances  the  dissolution  rate.   Hydrophilic  drug  
materials  tend to  dissolve  fast  regardless  of  the  size  distribution.  For  poorly  
water-soluble drugs however, the particle size affects the dissolution rate 
significantly, and micronized particles (r < 10 µm) are often used [78,89]. The 
most common methods for drug particle size reduction are milling, 
microemulsification and spray drying [84,89–92]. However, these methods 
are not free of complications and may not be suitable for certain compounds 
and applications [83,93–95].  
Electrospraying enables fabrication of monodisperse particles in both 
micro- and nanoscale, with sizes down to 10 nm (according to some reports 
even 2  -  4  nm) [13,19,48].  The particle  size  can be  controlled by the  means 
described in paragraphs 2.3 and 2.4. In addition, the drying pressure has been 




Similarly to the particle size reduction, dissolution enhancement by 
introducing porous particles is based on the growth of the specific surface 
area. Porous particles also have a small density compared to compact 
particles. These properties influence the functional properties of the drug 
remarkably.  Porous  or  shell  particles  have  proved  to  be  very  useful  for  
example in the pulmonary drug delivery [56,91]. 
The porosity of the particles produced by electrostatic and rotating disc at-
omisation  has  been  reported  to  depend  mainly  on  the  drying  conditions  
[10,56,96,97]. Quick drying in an elevated temperature tends to lead to for-
mation of porous or hollow particles, because the solvent evaporates faster 
than the concentration gradients inside the particle can equalize. The fast 
evaporation may result in an increased concentration of drug material on the 
droplet surface, and formation of a “skin layer”. In order to avoid the collapse 
of the skin layer and to attain solid and dense particles, small values of liquid 
flow rate have been recommended [98]. As to electrospraying polymer 
materials, reducing the drying pressure increased the surface roughness of the 
produced particles. Increasing the dissolved polymer concentration had a 
similar effect [55]. 
3.1.4 Amorphous materials 
Insolubility of a drug material is caused either by a limited ability to hydrogen 
bond with water (hydrophobicity) or by difficulty in breaking apart molecules 
in  the  solid  state  (high  lattice  energy)  [99].  Converting  crystalline  drug  
compounds  to  their  amorphous  counterparts  is  a  promising  tool  in  
improving the solubility, since the physical links between the drug molecules 
are weaker in the amorphous form [100–104]. The long-range order of 
molecular  packing  characteristic  to  a  crystalline  solid,  is  absent  in  the  
amorphous material. 
The drawback of using amorphous materials in pharmaceutical 
applications is their instability: amorphous solids are generally less stable 
than the corresponding crystals. Amorphous solids tend to crystallise during 
manufacturing,  storage  and  administration  (dissolution)  [102].  In  order  to  
avoid crystallisation, amorphous drugs can be formulated as solid 
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dispersions, corporated in mesoporous materials, treated with stabilising 
additives  and  stored  in  an  appropriate  temperature  and  humidity  
[102,103,105,106].  
Similarly  with  the  porosity,  the  drying  phase  is  most  likely  a  substantial  
factor regarding the formation of amorphous material during 
electrospraying. If the drying and solidification take place fast as is the case in 
spray drying, the molecules may not have enough time to arrange into 
crystals, which causes formation of amorphous material [84,94]. 
3.1.5 Crystal forms 
Depending  on  the  crystallisation  conditions,  some  solid  materials  possess  
more than one potential crystal structure, and the molecules may be aligned 
in different ways respect to one another in the crystal lattice. The different 
crystal  forms  of  the  same  substance  are  known  as  polymorphs.  A  classic  
example  of  crystalline  polymorphism  is  the  graphite  –  diamond  pair.  Since  
the different polymorphs possess varying lattice energies, the macroscopic 
properties  such as  melting point  and stability  of  the  material  depend on the  
polymorphic form [84]. 
In a drug molecule, the presence of many functional groups enables the 
multitude of hydrogen-bonding regimes. Therefore the majority of drug 
materials  exhibits  polymorphism  [107].  Often  it  is  of  a  form  known  as  
monotropic polymorphism, meaning that the lowest energy polymorph is the 
most stable one and will not convert to another form during storage as a drug 
product. The other polymorphs are described as metastable, and tend to 
spontaneously convert to the stable form with the rate depending on the 
storage conditions [84,108]. Crystalline solids can also contain a solvent 
molecule within the crystal structure. These adducts are known as solvates or 
pseudo polymorphs. If the incorporated solvent molecule is water, the solvate 
is termed a hydrate. 
During the course of development of a drug, usually the lowest energy 
polymorph is chosen for development to assure reproducible bioavailability 
of the product over its shelf life [108]. Any phase change due to polymorph 
conversion, desolvation of the solvates, formation of the hydrate or a change 
in  the  degree  of  crystallinity  may  alter  the  bioavailability.  However,  also  
metastable  crystalline  (or  amorphous)  forms may be  justifiable  because  of  a  
medical benefit, for example an increase in the dissolution rate. It is often 
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possible  to  improve  chemical  stability  of  such  forms  by  using  appropriate  
excipients and storage conditions [84,109–113]. Since polymorphism may 
have such a profound effect on the bioavailability of poorly soluble drugs, it is 
of great importance for manufacturers to chart the different polymorphs of a 
potential  product.  The  search  for  drug  polymorphs  is  a  complex  empirical  
exercise,  and  discrete  crystal  forms  are  considered  non-obvious  and  
patentable [114]. 
The surface temperature of the droplets formed in electrospraying 
decreases due to solvent evaporation, which may be of the essence on 
temperature dependent crystal transitions. In the study of Wang et al (2012), 
the energy of a drug molecule (carbamazepine) dipole in an electric field was 
estimated, and it was concluded that the fast evaporation and temperature 
decrease preponderated over the effect of electric field on the material 
crystallisation [98]. The produced nanoparticles were determined to be 
predominantly amorphous immediately after electrospraying, but the 
crystallisation could be accelerated by annealing at high temperatures. In 
another study on electrospraying drug (naproxen) nanosuspensions, the 
polymorph remained the same throughout the process, but slight decrease in 
the crystallinity and reduction in the size of the primary crystals (grains) were 
detected [115]. 
As stated in the previous paragraphs, the drying phase of electrospraying 
has  a  profound  effect  on  the  drug  particle  morphology.  The  spray  drying  
kinetics of biological and pharmaceutical materials and the subsequent 
particle morphology have been previously studied [116]. However, the effect 
of electric field and the electrospraying process on the morphology, 
crystallinity, and polymorphism of pharmaceutical materials during and after 
the process are not well understood [98].  
3.2 Electrospraying of biological materials 
When  electrospraying  is  used  for  processing  of  biological  or  other  fragile  
materials,  special  attention  should  be  paid  on  the  process  conditions.  The  
solvent must be chosen carefully, so that the molecules remain chemically 
stable in it.  With drug materials,  the main concern should be preserving the 
therapeutic  effect  of  the  material.  Ion  bombardment  and  the  possible  
formation of free radicals in an electric discharge could damage the materials. 
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In a previous spectroscopic study, the production of  OH-radicals which 
could be harmful to biological molecules, was reported to be negligible in the 
vicinity of an electrospraying nozzle [117]. The liquids used in the study were 
distilled water, methanol, ethanol and ethylene glycol. Also, the biological 
activity  of  insulin  was  found to  endure  the  electrospraying process,  and the  
secondary structure of a protein (bovine serum albumin) did not go through 
significant changes either [118,119]. Solutions containing living cells, viruses 
and bacteria have also been electrosprayed together with a shell or matrix 
material, and the organisms remained viable in the process [120–125]. 
According  to  these  findings,  the  biological  molecules  are  not  damaged  by  
electrospraying at fairly low voltages.  
3.3 Pharmaceutical applications 
Perhaps  the  best-known  biological  application  of  electrospray  is  its  use  for  
ion  production  in  mass  spectrometry  [126].  This  development  was  
recognised by Nobel Prize in Chemistry in 2002. There are a number of other 
potential biomedical applications that utilise electrospraying, ranging from 
implant coating to gene therapy. In the following, some promising reports are 
discussed. 
In  pulmonary  drug  administration,  small  particles  with  narrow  size  
distribution  are  required.  The  first  inhaler  known  to  be  based  on  
electrospraying was patented in 1989, and later further developed [34,127]. 
Electrosprays present a promising method for administering also DNA-based 
therapeutics  to  the  pulmonary  epithelium  [128].  The  potential  harm  to  the  
respiratory epithelium caused by the highly charged droplets has also been 
studied, and the effects were negligible [124]. Regardless of the number of 
academic  efforts  and  encouraging  results  in  designing  an  electrospray  
inhalation device, so far no commercial product is available [32,59,130,131]. 
Electrospraying can also be used for deposition of biological coatings with 
controlled surface morphology. In this process, the electrosprayed droplets 
including the coating material are directed towards a grounded substrate. 
After  solvent  evaporation,  a  thin  layer  is  formed  onto  the  substrate  surface.   
This method has been successfully used to fabricate biologically active 
coatings  on  metallic  implants,  which  enables  the  control  of  the  interaction  
between the implant and the surrounding tissue [132–135]. 
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Nanosized or nanostructured pharmaceutical particles can provide enhanced 
efficacy, solubility or biocompatibility, and administration at much lower 
dosages. Electrospraying has been used to produce polymer particles, which 
can  be  used  as  delivery  vehicles  for  bioactive  agents  in  the  nanoscale  
[10,58,136,137]. To prevent irreversible aggregation of the drug nanoparticles 
during drying, electrospraying has been used to produce redispersable drug 
nanoparticles  [115].  Also  solid  nanoparticles  of  pure  insulin  have  been  
produced and characterized [118]. 
As to electrospraying polymer materials, different shapes such as 
spherical, elongated, doughnut-shaped and fibrous particles can also be 
obtained. The final morphology can be tailored suitable for the drug delivery 
application in question, by judiciously selecting the polymer molecular 
weight, concentration and solution flow rate [97,138,139]. Also different 
shapes of drug (carbamazepine) particles have been produced by varying the 
dissolved drug concentration [140].  
3.4 Electrospray derivatives 
Electrostatic atomisation can be utilised not only to produce single 
component particles, but also capsules and matrix particles. The 
encapsulation can be implemented by electrospraying colloidal suspension of 
the core material, and solidifying the shell by solvent evaporation or 
immersing  in  a  gelatinising  or  polymerising  agent.  The  core  and  shell  
material  can  be  sprayed  from  single  or  separate  capillaries.  This  method  is  
referred to in the literature as electroencapsulation, and it can be used for 
example  to  deliver  a  core  drug  material  to  its  target  in  the  body  in  a  
controlled manner  [6,54,141–148].  
Another derivative of electrospraying that has been widely studied for bio-
medical applications is electrospinning [120,149–152]. This technique 
enables the production of polymeric multifunctional fibres in the micro- and 
nanoscale. In electrospinning, the desired polymer solution is atomised 
similarly  as  in  electrospraying,  but  the  ejected  jet  elongates  to  form  a  
continuous  fibre.  The  ordering  of  the  fibres  can  be  controlled  by  
manipulating the collector or the electric field [149]. For example, a portable 
electrospinning spraygun has been developed to produce fibrous wound 
dressing patches [63,153].  
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4 Aims of the Study 
An apparatus for electrospraying pharmaceutical materials was designed and 
built at the Laboratory of Industrial Physics (Department of Physics and As-
tronomy,  University  of  Turku)  in  2007  by  Matti  Murtomaa,  Olli-Pekka  
Hämäläinen and Mika Aarnio. Experiments on certain solvents and drug 
materials were performed at the time. Sustaining droplet and particle output 
in a scale adequate for process and product characterisation was nevertheless 
yet to be achieved.  
Early  on in  the  project,  the  study focused on finding suitable  parameters  
of  operation  (solvents,  liquid  flow  rates,  atomisation  and  neutralisation  
voltages,  drying pressures,  drug concentrations  etc.)  to  enable  stable  droplet  
production.  Determining  the  spray  functioning  modes  (Chapter  2.2)  of  
appropriate solvents was of the essence. Also, estimating the droplet and 
particle size as a function of liquid flow rate became an objective. Introducing 
the reduced drying pressure to the system brought about its own challenges 
in  the  form  of  possible  boiling  of  the  solvents,  clogging  of  the  capillaries,  
electric discharges and incomplete droplet neutralisation. Determining the 
working range of  the  apparatus  was  fundamental  at  the  beginning,  and it  is  
mostly discussed in paper I.  
Once the sample amounts had become adequate for experiments other 
than electron microscopy, emphasis was put on studying the produced 
particles (papers II,  III and IV). Particularly, the fast evaporation of solvents 
in the reduced pressure had raised questions about the amorphicity and 
porosity of the particles. Together with the size distribution, these 
characteristics are known to substantially affect the dissolution of drug 
materials. Therefore these properties and the possible correlation with the 
spraying  parameters  were  studied,  and  a  hypothesis  regarding  dissolution  
enhancement of poorly soluble drugs by electrospraying, was stated.  
In the course of the studies on the produced particles, some new findings 
were made. One of the model drug materials exhibited an unrecognised x-ray 
diffraction pattern after electrospraying. It was unclear whether this crystal 
structure was due to molecule degradation, formation of a solvate or an un-
known  polymorphic  form  of  the  material  in  question.  The  material  
crystallisation during electrospraying is not similar to slow crystallisation in a 
dish or even fast crystallisation achieved by spray drying, although the same 
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drug and solvent combination would be used. The electrospraying process 
involves  strong electric  fields,  temperature  gradients  and fast  evaporation of  
the solvent. Under these circumstances, for example polymorphic transitions 
may take place. At the final stage of the research, the objective was to discover 







The studies were performed using three model drugs: indomethacin, 
piroxicam and budesonide. Indomethacin (delivered by Hawkins 
Pharmaceutical, Roseville, MN, USA) is a light-sensitive drug used to relieve 
pain and inflammatory conditions. It is poorly soluble in water, and exists in 
at least two polymorphic crystalline forms: metastable -form and a stable -
form [154,155]. Piroxicam (Hawkins Pharmaceutical, Roseville, MN, USA) is 
a  potent,  non-steroidal  anti-inflammatory  drug.  It  is  also  poorly  soluble  in  
water and shows dissolution-rate-limited low oral bioavailability in the 
crystalline state [156].  Piroxicam exhibits polymorphism with the form 
designated as I being the most stable crystal structure [157,158]. Budesonide 
(Orion Corporation, Espoo, Finland) is an anti-inflammatory corticosteroid. 
It is so chemically and physically stable that it is almost insoluble to water at 
physiological pH, and it is not known to exhibit polymorphism [159].  
In electrospraying the most important properties of the solution are its 
conductivity, surface tension and viscosity. The solvents were chosen 
optimising  these  properties  and  taking  into  account  that  the  drug  materials  
have to be soluble, nevertheless chemically stable in them. Thus, ethanol and 
chloroform were chosen for the studies. 
5.2 Electrospraying 
A schematic of the electrostatic atomisation unit and the drying chamber 
is presented in Figure 4. Solutions were pumped continuously through a 
stainless steel capillary with a computer controlled syringe pump. The ca-
pillary  was  connected  to  a  high  voltage  (HV)  source  set  to  positive  
potential. The atomising electric field formed between the capillary and a 
grounded plate electrode beneath it.  The distance between these 
electrodes was fixed at ca. 1 cm. A circular metal plate (guard plate) was 
attached to HV conductor above the capillary, and maintained at the 
same  potential  as  the  capillary.  The  purpose  of  the  guard  plate  was  to  
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make  the  electric  field  near  the  capillary  tip  more  uniform,  and  to  
prevent external electric disturbances [7]. 
 
Fig. 4. Depressurisable drying chamber (on the left) and the electrostatic 
atomisation unit (on the right). The parts connected to high voltage sources are 
marked with a symbol HV. 
When the apparatus was used for particle production, the produced droplets 
were dried either under atmospheric or reduced pressure, the latter in order 
to  improve  the  drying  process.  The  drying  was  carried  out  in  a  cylindrical  
steel chamber under room temperature. The particles were collected on a 
vessel  located  at  the  bottom  of  the  chamber  (in  paper  III,  also  from  the  
chamber walls). 
The electrosprayed, highly charged droplets were neutralised in order 
to  avoid  adhesion  to  grounded  surfaces  and  further  disruption  at  the  
Rayleigh  limit.  This  was  done  using  a  corona  neutralisator  with  the  
configuration presented in Fig. 5. The corona needle was connected to a 
HV source set to negative potential, and the cylinder electrode 
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surrounding  the  needle  was  grounded.  A  stable  corona  burst  was  
maintained at the needle tip, which caused ionisation of the air and 
neutralisation of the cascading droplets.  
 
Fig. 5. Configuration of the corona neutralisator. Negative high voltage (HV) 
was connected to the needle electrode, which was insulated from the grounded 
cylinder electrode with a PTFE (polytetrafluoroethylene) sleeve. 
5.3 Process analysis 
In papers I and III, the electric charge carried by the droplets was measured 
by spraying the solutions directly into a Faraday pail. The pail was located ap-
proximately 3 cm below the capillary. The accumulated charge was measured 
with a Keithley 6517A electrometer (Keithley Instruments, Cleveland, OH, 
USA).  
5.4 Particle characterisation 
5.4.1 Scanning electron microscopy 
Produced particles were characterised with scanning electron microscope 
(SEM) for the size distribution, shape, porosity and crystal habit. In papers I – 
III,  the particles were collected on a nylon filter placed to the bottom of the 
drying  chamber.  The  filter  was  set  on  an  SEM  stub,  which  was  coated  with  
carbon conductive tape. To improve the conductivity, the samples were 
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coated with a 20-30 nm layer of gold or palladium. The particles were studied 
with  an  S200  SEM  system  (Cambridge  Instruments,  Cambridge,  UK).   In  
paper  IV,  a  part  of  the  samples  was  collected  also  from  the  bottom  of  the  
drying  chamber,  and  studied  with  a  Vega  SB  SEM  system  (Tescan  USA,  
Warrendale, PA, USA).  
An Image-Pro Plus  1.3  image analysis  software  (Media  Cybernetics,  Inc.,  
Rockville, MD, USA) was used in parallel with the SEM images to determine 
the particle size distribution of the fabricated particles.  
5.4.2 X-ray diffraction 
X-ray diffraction (XRD) was  utilised to  study the  crystallinity  and polymor-
phism of the electrosprayed particles. In papers I and II, the crystallinity was 
studied with PW 1830/1820/1710 diffractometer (Panalytical, Almelo, 
Netherlands).  In  paper  IV,  the  samples  were  studied with Scintag X-1 XRD 
system (Scintag Inc., Cupertino, CA, USA); or Philips X’Pert Pro MPD X-ray 
diffraction system, equipped with a PW3050/60 goniometer (Panalytical, 
Almelo, Netherlands) and a TTK 450 low temperature chamber (Anton Paar, 
Graz, Austria) for the variable temperature x-ray diffraction (VTXRD) 
measurements. Cu-K  radiation  and  scanning  speed  of  0.01  –  0.1  °/s  were  
used for all measurements, except for the VTXRD measurements where a 255 
channel PIXcel detector (Panalytical, Almelo, Netherlands) enabled a high 
combined scanning speed of 0.66 °/s. 
In  papers  I  and  II,  XRD  was  exploited  to  detect  and  quantify  the  
amorphous proportion in the electrosprayed samples. The presence of 
amorphous  content  leads  to  a  decrease  in  the  intensity  of  the  diffraction  
peaks [160]. The degree of crystallinity (DOC) of the samples was quantified 
by calculating the ratio of the integrated peak intensities of the sample and a 
crystalline reference after a programmatic background subtraction. By XRD, 
disorder  below  approximately  10  %  cannot  be  accurately  detected,  but  on  




5.4.3 Differential scanning calorimetry 
Differential scanning calorimetry (DSC) was used to determine the 
amorphicity  in  the  electrosprayed  drug  materials  (papers  I  and  II).  
Calorimetric  measurements  were  carried  out  using  Pyris  Diamond  DSC  
(PerkinElmer, Waltham, MA, USA) with a scanning speed of 10 °C/min. The 
calibration was done with an indium standard. The weighed samples were 
sealed in aluminium pans with holes, and measured under nitrogen gas flow. 
In a DSC thermogram, clear indications of amorphous content in the sample 
are glass transition, exothermic crystallisation peak and a decrease in the 
enthalpy of fusion [162–165]. In paper I, the degree of crystallinity (DOC) of 
the electrosprayed samples was calculated from the ratio of the heat of fusion 
of the sample and a crystalline reference. In paper II, the amorphicity of the 
samples  was  estimated  qualitatively  based  on  the  DSC  results,  and  
quantitatively  by  XRD.  The  detection  limit  of  DSC  is  reported  to  be  rather  
similar to that of XRD: the lower limit of detectable amorphous content is 
approximately  10  %  [166].  In  paper  IV,  DSC  was  used  to  study  the  
polymorphic form of the electrosprayed samples. 
5.4.4 Nitrogen adsorption 
The porosity of the electrosprayed particles was studied quantitatively with 
nitrogen adsorption in paper III. Nitrogen adsorption measurements at 77 K 
were done with TriStar 3000 gas sorption apparatus (Micromeritics, 
Norcross, GA, USA). The specific surface areas of the particles were 
determined  from  the  obtained  adsorption  isotherms  using  the  equation  by  
Brunauer, Emmett and Teller (BET equation) [167].  
5.4.5 UV spectroscopy 
In paper III, the dissolution of the electrosprayed drug particles in PBS (phos-
phate buffered saline, pH = 7.4) medium was studied. The studies were per-
formed at room temperature under sink conditions, defined as follows: the 
volume of the medium must be greater than three times that required to form 
a  saturated  solution  of  the  drug  substance  [85].  The  solution  was  set  on  a  
magnetic stirrer in a sealed vessel.  At appropriate time intervals, a sample of 
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the dissolution medium was withdrawn and immediately replaced with fresh 
medium. Subsequently, the samples were centrifuged to separate the non-
dissolved fraction of the drug material. The supernatants were collected, and 
the UV absorbance of the solutions was measured with a Lambda 25 UV-VIS 
spectrophotometer (PerkinElmer, Waltham, MA, USA) using quartz cells 
with a light path of  10  mm.  Based  on  the  Beer-Lambert  law  for  liquids,  the  
absorbance  is  directly  proportional  to  the  molar  concentration  of  the  
absorbing  species.  For  calibration,  standard  solutions  with  known  values  of  
concentration were fabricated and measured.  
5.4.6 Additional methods 
In paper IV, some additional techniques were utilised to study the crystalline 
structure of the electrosprayed piroxicam. To detect the possible molecule 
degradation  products,  the  total  piroxicam  content  and  the  stability  of  the  
drug were quantified by high performance liquid chromatography (HPLC, 
Agilent 1100 Series, Agilent Technologies, Waldbronn, Germany). The 
experimental details are presented in the original paper. 
The produced particles were also characterised by Raman and Fourier 
transform infrared (FTIR) spectroscopies. The Raman spectra were obtained 
with an InVia spectrometer (Renishaw, Wotton-under-Edge, UK) at a laser 
excitation wavelength of 785 nm. The FTIR spectra were collected with a 
Spectrum  BX  spectrometer  (PerkinElmer,  Waltham,  MA,  USA)  using  
MIRacle attenuated total reflectance accessory (Pike Technologies Inc., 
Madison, WI, USA).  
Also a thermogravimetric analysis was performed to detect the possible 
solvate removal. The measurements were performed with a TGA-7 
instrument (PerkinElmer, Waltham, MA, USA) at a heating rate of 10 °C/min 





6 Results and Discussion on Papers 
In the following section, a short discussion of each paper is presented. The 
experiments have been described in detail in the original papers, and the 
purpose of this chapter is merely to highlight the most important results. 
6.1 Paper I 
In  paper  I,  the  construction  of  the  apparatus  designed  for  electrospraying  
pharmaceutical materials was presented. The atomisation unit, electrode 
geometry and drying system were described. The setup was tested using pure 
solvent (ethanol) and a solution containing drug material (indomethacin). 
Experiments were performed both under atmospheric and reduced pressure. 
The essential variables in the studies were liquid flow rate and atomisation 
voltage.  
In this paper, emphasis was put on the measurements performed by 
Faraday pail and electrometer. The electric current carried by the 
electrosprayed ethanol droplets as a function of the atomisation voltage was 
measured (Fig. 3 of this thesis). The different functioning modes were clearly 
visible in the graph. The electric current was measured also as a function of 
the liquid flow rate. The size of the produced droplets was estimated based on 
their charge, approximating the charge level equal to 50 % of the Rayleigh 
limit. The results correlated fairly well with the scaling laws presented by De 
la Mora and Loscertales (1994) and Gañan-Calvo (1999) [15,29]. By this 
method, also the size of the produced particles was calculated and compared 
with the experimental results obtained by SEM. The calculated average sizes 
were consistent with the measured ones. Also, the degree of crystallinity 
(DOC) and the polymorphic form of the produced indomethacin particles 
were evaluated and discussed briefly.  
Paper I was more or less technical in nature. The electric charge meas-
urements were informative and useful regarding the forthcoming 
research.  At  the  time,  the  yield  of  the  process  was  low,  and  mainly  
microscopy  and  DSC  analysis  of  the  particles  was  feasible.  The  
polymorphic form was studied also by XRD, but the measurements were 
performed  with  a  very  small  amount  of  sample.  It  was  evident  that  the  
throughput had to be increased in order to study the produced particles 
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more profoundly. The results gave however a good indication of the 
nature  of  the  particles  that  could  be  produced  by  the  setup:  partly  
amorphous, very regularly shaped with diameters less than 10 µm and a 
narrow size distribution (Fig. 6).  
 
Fig. 6. SEM images of the indomethacin particles produced by electrospraying. 
(The structure on the background is the nylon filter on which the particles were 
collected.) 
6.2 Paper II 
By the time of the research related to paper II, some modifications had been 
made to the setup to improve the yield. The corona neutralisator had been 
moved closer to the jet and it was operated at slightly higher voltages. Liquid 
flow rates were also increased. The samples were collected not only on a 
nylon  filter,  but  also  from  the  bottom  of  the  drying  chamber.  Though  
appearing minor, these changes increased the particle production rate 
remarkably. 
Since producing adequate sample amounts for XRD measurements was 
possible, the studies of paper II focused on the amorphicity of the produced 
particles. The experiments were performed with three model drugs: 
indomethacin (dissolved in ethanol), piroxicam and budesonide (dissolved in 
chloroform). Special attention was paid on electrospraying under reduced 
pressure  and  the  effect  of  pressure  on  the  product  crystallinity.  All  the  
experiments were performed using stable cone-jet mode. 
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Regarding the particle shape and size distribution, the results were con-
sistent with those presented in paper I; all materials produced spherical, 
regularly shaped particles. The determined particle size distributions are 
presented in Fig. 7. 
 
Fig. 7. Particle size distributions of the electrosprayed indomethacin, piroxicam 
and budesonide particles. The number of analysed particles and the mean 
particle diameter are also included. 
The fabricated particles were analysed with DSC and XRD to study their 
crystallinity. Based on the XRD results,  the maximum degree of crystallinity 
(DOC) was calculated for the electrosprayed indomethacin and budesonide 
particles.  The  samples  contained  a  notable  proportion  of  amorphous  mate-
rial.  (For piroxicam, this sort of absolute degree of crystallinity could not be 
calculated due to the lack of crystalline reference.) The XRD measurement of 
the electrosprayed budesonide is presented in Fig. 8.  
For chloroform solutions (budesonide and piroxicam particles) 
electrospraying in the reduced pressure, led to formation of more 
amorphous particles than electrospraying in the atmospheric pressure. 
Instead for ethanol solutions (indomethacin particles), the results were 
quite the opposite: the particles produced in the atmospheric pressure 
were  more  amorphous.  It  was  concluded  that  this  was  due  to  the  fast  
evaporation of chloroform compared to ethanol: the pressure reduction 
at this range increased the amount of amorphous material only if the 
solution was volatile enough. With ethanol solutions, the droplet 
formation  in  the  reduced  pressure  was  too  irregular  after  all,  to  gain  a  





Fig. 8. The diffractograms of budesonide particles: electrosprayed in the 
pressure of 0.5 atm (1) and 1.0 atm (3). Diffractogram (2) is that of a 
crystalline reference measured with the same sample holder as (1). Similarly, 
diffractogram (4) represents the crystalline reference for (3). The measured 
peak positions of diffractograms (2)–(4) match with the referenced peak 
positions of budesonide. The Miller indices for some of the identified diffraction 
peaks are shown above the diffractograms (an asterisk denotes overlapping 
peaks). 
Determining  the  DOC  from  the  particles  produced  by  this  method  is  quite  
coarse  and dependent  on the  XRD data  processing techniques.  The possible  
crystallisation  during  sample  preparation  and  different  crystal  size  of  the  
sample  and  the  reference  may  cause  error  to  the  absolute  values  of  DOC.  
However, the peak areas obtained for atmospheric and reduced pressure 
samples can be reasonably compared, because the measurements include 
similar sources of error. The quantification of amorphous proportion by DSC 
can also be somewhat inaccurate, so it was used only to detect the amorphous 
content  in  the  present  study.  The  results  proved  to  be  useful  regarding  the  
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possible dissolution enhancement of poorly soluble drugs, achieved by 
electrospraying. They can also be beneficial for scientists designing 
electrospraying experiments: in some cases amorphous material is the desired 
outcome, in other applications its formation is disadvantageous. 
6.3 Paper III 
Also  in  paper  III  emphasis  was  put  on  the  properties  of  the  produced  
particles, yet also the technical features of the apparatus were supplemented 
through an experiment regarding the corona neutralisator. This experiment 
will be discussed first.  
The  functioning  of  the  neutralisator  was  tested  by  electrospraying  tap  
water directly into a Faraday pail. Four different values of liquid flow rate (Q) 
were used, and the accumulation of electric charge (q) into  the  pail  was  
measured with an electrometer. The high voltage of the neutralisator was 
switched on at t = 180 s point of time (Fig. 9).  
It can be noted in Fig. 9 that q increased linearly for all  values of Q until 
the neutralisator was switched on. After this point, q remained  at  the  same  
level or even decreased slightly. The results indicated that the neutralisator 
worked efficiently. 
In paper III, the effect of pressure reduction on particle morphology was 
further studied. In addition to amorphicity, the fast solvent evaporation may 
affect also other important particle properties: the size distribution, porosity 
and ultimately dissolution. These attributes were studied using budesonide as 
a model drug. It was dissolved in chloroform and electrosprayed using stable 
cone-jet mode under pressures of 0.5 – 1.0 atm. 
The fabricated budesonide particles were studied firstly with SEM. Based 
on  the  images,  the  particle  size  distributions  for  both  the  atmospheric  and  
reduced pressure samples were determined. These deviated very slightly. In 
the SEM images, the particles produced in the reduced pressure seemed more 
porous and hollow than the particles produced in atmospheric pressure 
(Fig. 10).  
To quantify the porosity, the specific surface areas of the particles were 
determined by nitrogen adsorption. For the particles produced in pressure of 
0.7 atm, the specific surface area was 1.6 times larger than that of the particles 




Fig. 9. Electrospraying of water into a Faraday pail using four different values 
of liquid flow rate (Q). The amount of cumulative charge (q) increased 
constantly until the neutralisator was switched on at t = 180 s. 
 
 
Fig. 10. Budesonide particles fabricated by electrospraying in atmospheric pres-




To  summarise,  in  paper  II  it  was  concluded  that  the  budesonide  particles  
produced in the reduced pressure were more amorphous than those 
produced in the atmospheric pressure. Also the porosity increased due to the 
pressure reduction, but the particle size remained roughly the same. Finally, 
the dissolution of the particles was studied with UV-spectrometry. The 
results  indicated  the  following:  for  particles  produced  in  the  pressure  of  
0.7  atm,  the  dissolution  was  faster  than  for  the  particles  produced  in  the  
pressure of 1.0 atm. However, no further improvement in the dissolution rate 
was detected as the pressure was reduced below 0.7 atm. This was most likely 
due  to  the  spraying  instabilities  occurring  at  low  pressures,  which  were  
discussed in more detail in the original paper. 
When designing the experiments of paper III, the dissolution test was con-
sidered to summarise the benefits of electrospraying under reduced pressure. 
However, the dissolution rate was improved only when the pressure was re-
duced  to  0.7  atm,  and  the  increase  was  not  as  remarkable  as  was  expected.  
The wettability of the amorphous and crystalline samples may be different, 
and therefore comparing the dissolution results directly may not be the most 
descriptive method. Therefore, if the increased dissolution rate is the main 
concern, using composite particles would perhaps be more advisable than 
pure drug materials.  
Nevertheless, when pharmaceutical particles with certain morphology are 
required, for example for pulmonary drug delivery, electrospraying is a 
potential method. As demonstrated in papers I-III, the particle properties can 
be controlled quite comprehensively by adjusting the aforementioned process 
parameters. Since electrospraying in the reduced pressure does not require 
elevated  temperatures,  it  may  be  an  appropriate  technique  to  process  also  
temperature sensitive materials.  
6.4 Paper IV 
The basis for the research related to paper IV was formed during the 
preparation  of  paper  II.  In  the  studies,  piroxicam  was  dissolved  in  
chloroform and electrosprayed.  It was noted that the diffractogram 
measured  for  the  electrosprayed  particles  did  not  match  with  any  of  the  
known piroxicam crystal structures (Cambridge Crystallographic Data 
Centre). Three polymorphic forms of piroxicam (known as I, II and III) 
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and  a  monohydrate  have  been  found  without  dispute  [157,158].  In  a  
previous study by another group, piroxicam was crystallised from 
chloroform and the obtained polymorph was either I or II depending on 
the cooling rate of the solution [168]. The x-ray diffractograms of the 
reported forms of piroxicam and the electrosprayed sample are presented 
in Fig. 11. 
 
Fig. 11. Calculated x-ray diffractograms of the known crystal forms of 
piroxicam, and the measured diffractogram of electrosprayed piroxicam. 
It was concluded that the piroxicam molecule may had degraded during the 
electrospraying process, and therefore it crystallised in an unrecognised form. 
Another possibility was formation of a solvate. Therefore the electrosprayed 
piroxicam particles were studied with HPLC, which however did not reveal 
any  degradation  products.  No  solvate  removal  was  detected  in  the  
calorimetric and thermogravimetric measurements either (Fig. 12).  
It  can  be  noted  in  Fig.  12,  that  the  melting  of  the  as-received  piroxicam  
batch (form I) takes place at a slightly higher temperature (202.9 °C) than that 
of  the  electrosprayed  samples  (199.6  °C).  Also,  the  melting  of  the  
electrosprayed samples is preceded by exothermic recrystallisation.  
Formation of a novel polymorphic form of piroxicam during 
electrospraying appeared possible. Therefore the electrosprayed particles 
were studied extensively by XRD. The unrecognised crystal structure 
remained intact even after 127 days of storage at room conditions. 
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A strong implication of a novel polymorphic form was obtained by 
variable temperature XRD: the material recrystallised completely into 
piroxicam  form  I  as  a  result  of  heating.  Also,  the  FTIR  and  Raman  
spectra of the electrosprayed piroxicam were compared to those of the 
form  I,  and  some  notable  differences  in  peak  positions,  shapes  and  
intensities were detected. Overall, the results indicated that 
electrospraying produced an as yet unreported polymorph of piroxicam. 
Crystallisation of this form was independent of the values of atomisation 
voltage, liquid flow rate and drying pressure at the applied range. 
 
Fig. 12. DSC scans of the original piroxicam powder (1) and piroxicam elec-
trosprayed at atmospheric pressure (2 – 5). 
In electrospraying, the conditions for material crystallisation are drastic:  
formation of small highly charged droplets in a strong electric field, followed 
by  fast  evaporation  of  the  solvent.  Under  the  influence  of  a  strong  electric  
field, the drug molecules may be forced to align in the direction of the field in 
the  solution.  Due to  the  small  droplet  size  and fast  solvent  evaporation,  the  
molecules may remain in this position after exiting the field, which may 





In this thesis, a setup for electrospraying pharmaceutical materials was pre-
sented. The produced droplets were dried both under atmospheric pressure, 
and in order to improve the drying process, under reduced pressure. To avoid 
adhesion to grounded surfaces and further disruption, the electrosprayed 
droplets were neutralised with a corona neutralisator. By this method, 
microscale particles with narrow size distribution were produced using 
indomethacin, piroxicam and budesonide as model drugs. 
The effects of electrospraying on the morphology, crystallinity, and poly-
morphism  of  pharmaceutical  materials  during  and  after  the  process  are  
generally not well understood. Several parameters can be varied during the 
process, each of which may have an effect on the particle properties. In this 
thesis  the  size  distribution,  degree  of  crystallinity,  polymorphic  form  and  
porosity of the produced particles were studied. Special emphasis was put on 
the effects of drying pressure on these properties. The results of the samples 
obtained in reduced pressure were compared to those of the atmospheric 
pressure batches. When a volatile solvent (chloroform) was used, the 
amorphicity  and  porosity  of  the  product  increased  due  to  the  pressure  
reduction. The particle size remained roughly the same. In addition, the 
possibilities  to  improve  the  dissolution  of  poorly  soluble  drugs  by  
electrospraying were estimated. By using a moderate pressure reduction, the 
dissolution was slightly improved. 
Since electrospraying in the reduced pressure does not require elevated 
temperatures, it may be an appropriate technique to process temperature 
sensitive materials. The electrostatic atomisation itself has proved to be a 
non-destructive method for processing biological materials. With drug 
materials, the main concern should be preserving the therapeutic effect of the 
material.  As  demonstrated in  papers  I-III  of  this  thesis  and previous  studies  
by  other  groups,  the  particle  properties  can  be  controlled  quite  
comprehensively by adjusting the process parameters. When pharmaceutical 
particles with certain morphology are required, electrospraying is a very 
potential method.  
The  search  for  drug  polymorphs  is  a  complex  empirical  exercise,  and  
discrete crystal forms are considered non-obvious. In paper IV, it was shown 
that  by  utilising  electrostatic  atomisation,  production  of  new  polymorphs  is  
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feasible. To the best of author’s knowledge, electrospraying has previously 
been used in drug particle production mainly to fabricate micro- (and nano-) 
particles with appropriate properties for certain drug delivery application. 
Therefore, the scope presented in paper IV and this thesis is novel, and the 
technique should be applicable to other drug materials as well. The material 
crystallisation during electrospraying is not similar to slow crystallisation in a 
dish or  even fast  crystallisation processes  (spray drying),  although the  same 
drug  and  solvent  combination  would  be  used.  The  process  involves  strong  
electric fields, possible temperature gradients and fast evaporation of the 
solvent.  Under  these  conditions,  formation  of  new  exiting  crystal  forms  is  
possible,  and electrospraying may offer  a  valuable  tool  in  the  search of  new 
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